ID   RMG-V
AC   CVCL_M716
DR   JCRB; JCRB1729
DR   TKG; TKG 0720
DR   Wikidata; Q54950672
RX   PubMed=17022146;
CC   Population: Japanese.
CC   Doubling time: 15.5 hours (PubMed=17022146).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1729
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D5S818: 10,11
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 13
//
RX   PubMed=17022146; DOI=10.1111/j.1749-0774.2005.tb00004.x;
RA   Aoki, Daisuke
RA   Suzuki, Nao
RA   Susumu, Nobuyuki
RA   Noda, Tomomi
RA   Suzuki, Atsushi
RA   Tamada, Yutaka
RA   Higashiguchi, Atsushi
RA   Oie, Shinji
RA   Nozawa, Shiro
RT   "Establishment and characterization of the RMG-V cell line from human
RT   ovarian clear cell adenocarcinoma.";
RL   Hum. Cell 18:143-146(2005).
//